C000213841 Fees and Costs — BlackRock LifePath Smart Beta 2065 Fund
Data updated: 2020-06-24
The net expense ratio is 0.79% (1.91% before fee waivers). There are no sales loads or redemption fees.
C000213841 Fees and Expenses
Annual operating expenses and sales charges of C000213841. Prospectus, as of February 29, 2020.
| Annual operating expenses | |
|---|---|
| Management fee | 0.00% |
| 12b-1 fee | 0.50% |
| Other expenses | 1.21% |
| Gross expense ratio | 1.91% |
| Fee waiver | −1.12% |
| Net expense ratio | 0.79% |
| Sales charges | |
|---|---|
| Max front load | 0.00% |
| Max deferred load | 0.00% |
| Redemption fee | — |
C000213841 Costs Over Time
On $10,000 invested in C000213841, assuming 5% a year before costs, total costs come to $496 over 5 years, cutting the return by 0.83% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).
| $10,000 invested | Sell after 1 year | Sell after 3 years | Sell after 5 years |
|---|---|---|---|
| Value before costs | $10,500 | $11,576 | $12,763 |
| Fund expenses (net expense ratio 0.79%) | $83 | $259 | $451 |
| Lost growth on money paid in costs | $0 | $13 | $45 |
| Total costs | $83 | $272 | $496 |
| Value after costs | $10,417 | $11,304 | $12,267 |
| Impact on return, per year | 0.83% | 0.83% | 0.83% |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.